BridgeMD
New treatment option for Obesity
Official title Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery
ClinicalTrials.gov ID: NCT03756961
What this study is testing
What is Dexmedetomidine?
Dexmedetomidine is an investigational medicine, being studied as a potential treatment for obesity.
Also referred to as Dexdor.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The opioid consumption has exploded in the western world, and for some patient populations such as obese patients, patients with sleep apnoea or patients undergoing cancer treatment, opioid-sparing/ opioid-free strategies could have positive effects on outcomes. Studies suggest that opioids could have opioid-induced immunosuppression, induce chronic post-operative pain syndrome and hyperalgesia in addition to the more well-known side effects such as respiratory depression, nausea, bladder, and bowel dysfunction.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- -Patients ≥18 years planned to undergo laparoscopic obesity surgery (GBP alt Sleeve surgery) at the selected site.
You likely can't join if
- ASA\> III
- Cardiovascular disease with bradycardia (\<50 bpm)
- Serious liver disease failure
- Insufficient knowledge of the Swedish language
- Serious untreated psychiatric disease
- Neurocognitive dysfunction
See the full eligibility criteria
- -Patients ≥18 years planned to undergo laparoscopic obesity surgery (GBP alt Sleeve surgery) at the selected site.
- ASA\> III
- Cardiovascular disease with bradycardia (\<50 bpm)
- Serious liver disease failure
- Insufficient knowledge of the Swedish language
- Serious untreated psychiatric disease
- Neurocognitive dysfunction
- Pregnancy
- Women of childbearing age without contraception
- Malignant disease with expected short survival
- Patients treated with opioids for chronic pain
- Substance abuse
- Hypersensitivity to Oxycodone, Esketamine, Dexmedetomidine, and Lidocaine
- Pacemaker or ICD
- Inability to fill in questionnaires
- Decline participation,
The study team makes the final eligibility decision.
Where it's taking place
- Lindesberg, Region Örebro, Sweden
- Gothenburg, VG, Sweden
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lindesberg, Region Örebro, Sweden; Gothenburg, VG, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.